Synlait cuts debt but auditors flag material going-concern uncertainty

Recovery arrives before the balance sheet is secure

Synlait Milk Limited (NZX:SML, ASX:SM1) finished FY26 with a NZ$75.4 million net loss, but the more consequential line in its annual report may be the auditor’s warning that a material uncertainty exists over the company’s ability to continue as a going concern. KPMG did not modify its audit opinion, yet Synlait’s forecasts depend on sustained operating improvement, covenant compliance, China regulatory approval and refinancing debt facilities that mature through 2027.

The contrast within the year is stark. Reported EBITDA moved from a NZ$34.7 million loss in the first half to NZ$42.8 million in the second, while reported net profit after tax improved from a NZ$80.6 million loss to a NZ$5.2 million profit. The latter was helped by a NZ$26 million gain on the sale of the North Island assets, so the statutory turnaround is not purely operational. Underlying EBITDA rose to NZ$42.2 million in the second half from NZ$4.1 million, but full-year underlying NPAT remained a NZ$21.6 million loss.

Dunsandel performs better, but cash remains the pressure point

Synlait said manufacturing stability improved after repairs, maintenance work, strengthened quality controls and workforce training. Products manufactured in specification rose from 91% in the first half to 95% in the second, while production-plan attainment increased from about 90% to 103%. The full-year manufactured-in-specification measure was 93%, up from 88% in FY25.

Those gains have not yet translated into cash. Operating cash flow swung from a NZ$165.5 million inflow in FY25 to a NZ$183.3 million outflow in FY26, as receivables, inventory and other working-capital requirements rose alongside weaker operating performance. Revenue increased 6% to NZ$1.94 billion, but gross profit fell to NZ$37.7 million from NZ$105.3 million. Advanced Nutrition gross profit dropped 78% to NZ$20.9 million, while Ingredients gross profit fell 26% to NZ$9.7 million. Consumer and Foodservice were the brighter spots, with gross profit rising 32% to NZ$51.7 million and reaching NZ$11 million respectively.

Asset sale cuts debt, not the refinancing requirement

The April sale of the North Island operations to Abbott delivered NZ$295.7 million of cash proceeds and helped reduce reported net debt by NZ$35.7 million to NZ$215 million. Synlait also completed a NZ$320 million syndicated bank refinancing and replaced its NZ$130 million Bright Dairy shareholder loan, which now matures in July 2028. The refinancing gives the business more room to operate, but it does not remove the need to generate cash and maintain lender confidence.

Bank facilities reduce progressively through the 2026/27 milk season, with material portions maturing by June 2027. Synlait says the facilities due then are not expected to be repaid solely from available cash and will need to be refinanced or replaced. The company complied with its covenants at 31 July 2026, but minimum EBITDA requirements increase during FY27 and replacement funding has not been secured. The report therefore places the burden of proof on the recovery: better production must become reliable earnings, then reliable cash generation.

New customers and China approval form the next test

Management is targeting the capacity left by The a2 Milk Company shifting some production to its Pōkeno facility. Synlait has signed a FY27 agreement with a Middle Eastern customer and says other opportunities are in advanced discussions, although Advanced Nutrition customer onboarding can take two to three years. The company is also pursuing growth in Foodservice, Consumer and higher-value ingredients rather than relying as heavily on a narrow customer and product base.

The immediate reporting period will offer limited clarity: Synlait has changed its balance date from 31 July to 31 December and will not provide quantitative earnings guidance for the five-month transition period ending 31 December 2026. KPMG noted that August performance was ahead of management expectations and September production was generally tracking at or ahead of plan, but also cautioned that the evidence covers only a short period. The harder milestones sit further out, including renewal of the State Administration for Market Regulation registration by 5 September 2027 and refinancing the senior facilities before June 2027.